by TractManager | Apr 28, 2011 | Emerging Technology Report
A first-in-class oral CYP17 inhibitor proposed initially for use in combination with prednisone to treat metastatic castration-resistant prostate cancer (CRPC) in patients previously treated with a docetaxel chemotherapy. If you have a Hayes login, click here to...
by TractManager | Apr 19, 2011 | Emerging Technology Report
An intravenous monoclonal antibody to the interleukin-6 receptor, proposed for the second- or third-line treatment of children with juvenile idiopathic arthritis. If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Apr 18, 2011 | Emerging Technology Report
An intravenous antiarrhythmic for the conversion of recent onset atrial fibrillation to sinus rhythm. If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments